Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.

Alzheimer’s disease; MTsat; Multivariate analysis; PET; Quantitative MRI; R2*; Total volume distribution; Iron; Male; Humans; Brain/diagnostic imaging; Brain/pathology; Magnetic Resonance Imaging/methods; Multimodal Imaging/methods; Atrophy/pathology; Alzheimer Disease/diagnostic imaging; Alzheimer Disease/pathology; Demyelinating Diseases; Atrophy; Brain; Magnetic Resonance Imaging; Multimodal Imaging; Neuroscience (all); Aging; Neurology (clinical); Developmental Biology; Geriatrics and Gerontology; General Neuroscience

Abstract :

[en] Multiple neuropathological events are involved in Alzheimer's disease (AD). The current study investigated the concurrence of neurodegeneration, increased iron content, atrophy, and demyelination in AD. Quantitative multiparameter magnetic resonance imaging (MRI) maps providing neuroimaging biomarkers for myelination and iron content along with synaptic density measurements using [18F] UCB-H PET were acquired in 24 AD and 19 Healthy controls (19 males). The whole brain voxel-wise group comparison revealed demyelination in the right hippocampus, while no significant iron content difference was detected. Bilateral atrophy and synaptic density loss were observed in the hippocampus and amygdala. The multivariate GLM (mGLM) analysis shows a bilateral difference in the hippocampus and amygdala, right pallidum, left fusiform and temporal lobe suggesting that these regions are the most affected despite the diverse differences in brain tissue properties in AD. Demyelination was identified as the most affecting factor in the observed differences. Here, the mGLM is introduced as an alternative for multiple comparisons between different modalities, reducing the risk of false positives while informing about the co-occurrence of neuropathological processes in AD.

Disciplines :

Human health sciences: Multidisciplinary, general & others

Author, co-author :

Moallemian, Soodeh ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Salmon, Eric ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Bahri, Mohamed Ali ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Beliy, Nikita ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Delhaye, Emma ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Balteau, Evelyne ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Neuroimaging, data acquisition and processing

Degueldre, Christian ; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

Phillips, Christophe ^✱; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Neuroimaging, data acquisition and processing

Bastin, Christine ^✱; Université de Liège - ULiège > GIGA > GIGA CRC In vivo Imaging - Aging & Memory

^✱ These authors have contributed equally to this work.

Language :

English

Title :

Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.

Publication date :

December 2023

Journal title :

Neurobiology of Aging

ISSN :

0197-4580

eISSN :

1558-1497

Publisher :

Elsevier Inc., United States

Volume :

132

Pages :

24 - 35

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://api.elsevier.com/content/article/PII:S0197458023002002?httpAccept=text/xml

Funding text :

Funding: This work was supported by the ULiege Research Concerted Action (SLEEPDEM, grant 17/2109 ) and Walloon Region in the framework of the PIT program PROTHER-WAL under grant agreement No. 7289. [18F]flutemetamol was provided by GE Healthcare. CB is a Senior Research Associate at the F.R.S.-FNRS and CP is a Research Director at the F.R.S.-FNRS.Funding: This work was supported by the ULiege Research Concerted Action (SLEEPDEM, grant 17/2109) and Walloon Region in the framework of the PIT program PROTHER-WAL under grant agreement No. 7289. [18F]flutemetamol was provided by GE Healthcare. CB is a Senior Research Associate at the F.R.S.-FNRS and CP is a Research Director at the F.R.S.-FNRS.

Available on ORBi :

since 22 January 2024

Statistics

Number of views

124 (20 by ULiège)

Number of downloads

97 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Acosta-Cabronero, J., Betts, M.J., Cardenas-Blanco, A., Yang, S., Nestor, P.J., In vivo MRI mapping of brain iron deposition across the adult lifespan. J. Neurosci. 36 (2016), 364–374, 10.1523/JNEUROSCI.1907-15.2016.
Acosta-Cabronero, J., Williams, G.B., Cardenas-Blanco, A., Arnold, R.J., Lupson, V., Nestor, P.J., In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS ONE, 8, 2013, e81093, 10.1371/journal.pone.0081093.
Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., Holtzman, D.M., Jagust, W.J., Petersen, R.C., Snyder, P.J., Carrillo, M.C., Thies, B., Phelps, C.H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. J. Alzheimer's Assoc. 7 (2011), 270–279, 10.1016/j.jalz.2011.03.008.
Ashburner, J., A fast diffeomorphic image registration algorithm. NeuroImage 38 (2007), 95–113, 10.1016/j.neuroimage.2007.07.007.
Ashburner, J., Friston, K.J., Unified segmentation. NeuroImage 26 (2005), 839–851, 10.1016/j.neuroimage.2005.02.018.
Ayton, S., Faux, N.G., Bush, A.I., Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat. Commun., 6, 2015, 6760, 10.1038/ncomms7760.
Azam, S., Haque, M.E., Balakrishnan, R., Kim, I.-S., Choi, D.-K., The ageing brain: molecular and cellular basis of neurodegeneration. Front. Cell Dev. Biol., 9, 2021, 683459, 10.3389/fcell.2021.683459.
Bahri, M.A., Plenevaux, A., Aerts, J., Bastin, C., Becker, G., Mercier, J., Valade, A., Buchanan, T., Mestdagh, N., Ledoux, D., Seret, A., Luxen, A., Salmon, E., Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimer's Dement. Transl. Res. Clin. Interv. 3 (2017), 481–486, 10.1016/j.trci.2017.08.004.
Bartzokis, G., Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32 (2011), 1341–1371, 10.1016/j.neurobiolaging.2009.08.007.
Bastin, C., Bahri, M.A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., Salmon, E., In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging 47 (2020), 390–402, 10.1007/s00259-019-04461-x.
Bulk, M., Abdelmoula, W.M., Nabuurs, R.J.A., van der Graaf, L.M., Mulders, C.W.H., Mulder, A.A., Jost, C.R., Koster, A.J., van Buchem, M.A., Natté, R., Dijkstra, J., van der Weerd, L., Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease. Neurobiol. Aging 62 (2018), 231–242, 10.1016/j.neurobiolaging.2017.10.017.
Calabrò, M., Rinaldi, C., Santoro, G., Crisafulli, C., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy, The biological pathways of Alzheimer's disease: a review. AIMS Neurosci. 8 (2021), 86–132, 10.3934/Neuroscience.2021005.
Callaghan, M.F., Freund, P., Draganski, B., Anderson, E., Cappelletti, M., Chowdhury, R., Diedrichsen, J., FitzGerald, T.H.B., Smittenaar, P., Helms, G., Lutti, A., Weiskopf, N., Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol. Aging 35 (2014), 1862–1872, 10.1016/j.neurobiolaging.2014.02.008.
Chen, G., Adleman, N.E., Saad, Z.S., Leibenluft, E., Cox, R.W., Applications of multivariate modeling to neuroimaging group analysis: a comprehensive alternative to univariate general linear model. NeuroImage 99 (2014), 571–588, 10.1016/j.neuroimage.2014.06.027.
Chen, J.-F., Liu, K., Hu, B., Li, R.R., Xin, W., Chen, H., Wang, F., Chen, L., Li, R.X., Ren, S.Y., Xiao, L., Chan, J.R., Mei, F., Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer's disease. Neuron 109:14 (2021), 2292–2307, 10.1016/j.neuron.2021.05.012 e5, Epub 2021 Jun 7. PMID: 34102111; PMCID: PMC8298291.
Chen, M.-K., Mecca, A.P., Naganawa, M., Finnema, S.J., Toyonaga, T., Lin, S., Najafzadeh, S., Ropchan, J., Lu, Y., McDonald, J.W., Michalak, H.R., Nabulsi, N.B., Arnsten, A.F.T., Huang, Y., Carson, R.E., van Dyck, C.H., Assessing synaptic density in Alzheimer's disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol., 75, 2018, 1215, 10.1001/jamaneurol.2018.1836.
Dean, D.C., Hurley, S.A., Kecskemeti, S.R., O'Grady, J.P., Canda, C., Davenport-Sis, N.J., Carlsson, C.M., Zetterberg, H., Blennow, K., Asthana, S., Sager, M.A., Johnson, S.C., Alexander, A.L., Bendlin, B.B., Association of amyloid pathology with myelin alteration in preclinical Alzheimer's disease. JAMA Neurol. 74 (2017), 41–49, 10.1001/jamaneurol.2016.3232.
DeKosky, S.T., Scheff, S.W., Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990), 457–464, 10.1002/ana.410270502.
Draganski, B., Ashburner, J., Hutton, C., Kherif, F., Frackowiak, R.S.J., Helms, G., Weiskopf, N., Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ). NeuroImage 55 (2011), 1423–1434, 10.1016/j.neuroimage.2011.01.052.
Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., Scheltens, P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol. 6 (2007), 734–746, 10.1016/S1474-4422(07)70178-3.
Gonneaud, J., Chételat, G., Which is to blame for cognitive decline in ageing: amyloid deposition, neurodegeneration or both?. Brain J. Neurol. 141 (2018), 2237–2241, 10.1093/brain/awy174.
Gorgolewski, K.J., Auer, T., Calhoun, V.D., Craddock, R.C., Das, S., Duff, E.P., Flandin, G., Ghosh, S.S., Glatard, T., Halchenko, Y.O., Handwerker, D.A., Hanke, M., Keator, D., Li, X., Michael, Z., Maumet, C., Nichols, B.N., Nichols, T.E., Pellman, J., Poline, J.-B., Rokem, A., Schaefer, G., Sochat, V., Triplett, W., Turner, J.A., Varoquaux, G., Poldrack, R.A., The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Sci. Data, 3, 2016, 160044, 10.1038/sdata.2016.44.
Gulisano, W., Maugeri, D., Baltrons, M.A., Fà, M., Amato, A., Palmeri, A., D'Adamio, L., Grassi, C., Devanand, D.P., Honig, L.S., Puzzo, D., Arancio, O., Role of amyloid-β and tau proteins in Alzheimer's disease: confuting the amyloid cascade. J. Alzheimer's Dis. 64 (2018), S611–S631, 10.3233/JAD-179935.
Gyger, L., Ramponi, C., Mall, J.F., Swierkosz-Lenart, K., Stoyanov, D., Lutti, A., von Gunten, A., Kherif, F., Draganski, B., Temporal trajectory of brain tissue property changes induced by electroconvulsive therapy. NeuroImage, 232, 2021, 117895, 10.1016/j.neuroimage.2021.117895.
Helms, G., Dechent, P., Increased SNR and reduced distortions by averaging multiple gradient echo signals in 3D FLASH imaging of the human brain at 3T. J. Magn. Reson. Imaging JMRI 29 (2009), 198–204, 10.1002/jmri.21629.
Jack, C.R., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., Shaw, L.M., Vemuri, P., Wiste, H.J., Weigand, S.D., Lesnick, T.G., Pankratz, V.S., Donohue, M.C., Trojanowski, J.Q., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12 (2013), 207–216, 10.1016/S1474-4422(12)70291-0.
Jack, C.R., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J.L., Montine, T., Phelps, C., Rankin, K.P., Rowe, C.C., Scheltens, P., Siemers, E., Snyder, H.M., Sperling, R., Contributors, Elliott, C., Masliah, E., Ryan, L., Silverberg, N., NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's Dement. 14 (2018), 535–562, 10.1016/j.jalz.2018.02.018.
Jeremic, D., Jiménez-Díaz, L., Navarro-López, J.D., Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review. Ageing Res. Rev., 72, 2021, 101496, 10.1016/j.arr.2021.101496.
Kalpouzos, G., Garzón, B., Sitnikov, R., Heiland, C., Salami, A., Persson, J., Bäckman, L., Higher striatal iron concentration is linked to frontostriatal underactivation and poorer memory in normal aging. Cereb. Cortex 27 (2017), 3427–3436, 10.1093/cercor/bhx045.
Karakuzu, A., Appelhoff, S., Auer, T., Boudreau, M., Feingold, F., Khan, A.R., Lazari, A., Markiewicz, C., Mulder, M., Phillips, C., Salo, T., Stikov, N., Whitaker, K., de Hollander, G., qMRI-BIDS: an extension to the brain imaging data structure for quantitative magnetic resonance imaging data. Sci. Data, 9, 2022, 517, 10.1038/s41597-022-01571-4.
Knudsen, G.M., Ganz, M., Appelhoff, S., Boellaard, R., Bormans, G., Carson, R.E., Catana, C., Doudet, D., Gee, A.D., Greve, D.N., Gunn, R.N., Halldin, C., Herscovitch, P., Huang, H., Keller, S.H., Lammertsma, A.A., Lanzenberger, R., Liow, J.-S., Lohith, T.G., Lubberink, M., Lyoo, C.H., Mann, J.J., Matheson, G.J., Nichols, T.E., Nørgaard, M., Ogden, T., Parsey, R., Pike, V.W., Price, J., Rizzo, G., Rosa-Neto, P., Schain, M., Scott, P.J., Searle, G., Slifstein, M., Suhara, T., Talbot, P.S., Thomas, A., Veronese, M., Wong, D.F., Yaqub, M., Zanderigo, F., Zoghbi, S., Innis, R.B., Guidelines for the content and format of PET brain data in publications and archives: a consensus paper. J. Cereb. Blood Flow Metab. 40 (2020), 1576–1585, 10.1177/0271678X20905433.
Li, Y., Sethi, S.K., Zhang, C., Miao, Y., Yerramsetty, K.K., Palutla, V.K., Gharabaghi, S., Wang, C., He, N., Cheng, J., Yan, F., Haacke, E.M., Iron content in deep gray matter as a function of age using quantitative susceptibility mapping: a multicenter study. Front. Neurosci., 14, 2021, 10.3389/fnins.2020.607705.
Lutti, A., Hutton, C., Finsterbusch, J., Helms, G., Weiskopf, N., Optimization and validation of methods for mapping of the radiofrequency transmit field at 3T. Magn. Reson. Med. 64 (2010), 229–238, 10.1002/mrm.22421.
Mc Donald, J.M., Savva, G.M., Brayne, C., Welzel, A.T., Forster, G., Shankar, G.M., Selkoe, D.J., Ince, P.G., Walsh, D.M., The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia. Brain 133 (2010), 1328–1341, 10.1093/brain/awq065.
Mcfarquhar, M., Williams, S., Mckie, S., Emsley, R., Suckling, J., Elliott, R., Multivariate and repeated measures (MRM): a new toolbox for dependent and multimodal group-level neuroimaging data. NeuroImage 132 (2016), 373–389, 10.1016/j.neuroimage.2016.02.053.
McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C., Rossor, M.N., Scheltens, P., Carrillo, M.C., Thies, B., Weintraub, S., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. J. Alzheimer's Assoc. 7 (2011), 263–269, 10.1016/j.jalz.2011.03.005.
Munsch, F., Varma, G., Taso, M., Girard, O., Guidon, A., Duhamel, G., Alsop, D.C., Characterization of the cortical myeloarchitecture with inhomogeneous magnetization transfer imaging (ihMT. NeuroImage, 225, 2021, 117442, 10.1016/j.neuroimage.2020.117442.
Peng, Y., Chang, X., Lang, M., Iron homeostasis disorder and Alzheimer's disease. Int. J. Mol. Sci., 22, 2021, 12442, 10.3390/ijms222212442.
Peters, A., The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 31:8-9 (2002), 581–593, 10.1023/a:1025731309829 PMID: 14501200.
Preibisch, C., Deichmann, R., Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles. Magn. Reson. Med. 61 (2009), 125–135, 10.1002/mrm.21776.
Scheff, S.W., Price, D.A., Schmitt, F.A., Mufson, E.J., Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27 (2006), 1372–1384, 10.1016/j.neurobiolaging.2005.09.012.
Spillantini, M.G., Goedert, M., Tau pathology and neurodegeneration. Lancet Neurol. 12 (2013), 609–622, 10.1016/S1474-4422(13)70090-5.
Steiger, T.K., Weiskopf, N., Bunzeck, N., Iron level and myelin content in the ventral striatum predict memory performance in the aging brain. J. Neurosci. 36 (2016), 3552–3558, 10.1523/JNEUROSCI.3617-15.2016.
Su, L., Blamire, M., Watson, A., He, R., Aribisala, J., B., T. O128;TMBrien, J, Cortical and subcortical changes in Alzheimer's disease: a longitudinal and quantitative MRI study. Curr. Alzheimer Res. 13 (2016), 534–544.
Tabachnick, B.G., Fidell, L.S., Using Multivariate Statistics, 5th ed., 2007, Pearson/Allyn and Bacon, Boston.
Tabelow, K., hMRI—a toolbox for quantitative MRI in neuroscience and clinical research. NeuroImage 194 (2019), 191–210, 10.1016/j.neuroimage.2019.01.029.
Tan, C.-C., Yu, J.-T., Tan, L., Biomarkers for preclinical Alzheimer's disease. J. Alzheimer's Dis. JAD 42 (2014), 1051–1069, 10.3233/JAD-140843.
Tan, C.-C., L.T, Yu, J.T., Biomarkers for preclinical Alzheimer's disease. J. Alzheimer's JAD, 2014.
Taubert, M., Roggenhofer, E., Melie-Garcia, L., Muller, S., Lehmann, N., Preisig, M., Vollenweider, P., Marques-Vidal, P., Lutti, A., Kherif, F., Draganski, B., Converging patterns of aging-associated brain volume loss and tissue microstructure differences. Neurobiol. Aging 88 (2020), 108–118, 10.1016/j.neurobiolaging.2020.01.006.
Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991), 572–580, 10.1002/ana.410300410.
Thomas, B.A., Cuplov, V., Bousse, A., Mendes, A., Thielemans, K., Hutton, B.F., Erlandsson, K., PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography. Phys. Med. Biol. 61 (2016), 7975–7993, 10.1088/0031-9155/61/22/7975.
Timmler, S., Simons, M., Grey matter myelination. Glia 67 (2019), 2063–2070, 10.1002/glia.23614.
van Duijn, S., Bulk, M., van Duinen, S.G., Nabuurs, R.J.A., van Buchem, M.A., van der Weerd, L., Natté, R., Cortical iron reflects severity of Alzheimer's disease. J. Alzheimer's Dis. 60:4 (2017), 1533–1545, 10.3233/JAD-161143 PMID: 29081415; PMCID: PMC5676973.
Varma, G., Munsch, F., Burns, B., Duhamel, G., Girard, O.M., Guidon, A., Lebel, R.M., Alsop, D.C., Three-dimensional inhomogeneous magnetization transfer with rapid gradient-echo (3D ihMTRAGE) imaging. Magn. Reson. Med. 84 (2020), 2964–2980, 10.1002/mrm.28324.
Villemagne, V.L., Pike, K.E., Chételat, G., Ellis, K.A., Mulligan, R.S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., Martins, R., O'Keefe, G., Mathis, C.A., Klunk, W.E., Ames, D., Masters, C.L., Rowe, C.C., Longitudinal assessment of Aβ and cognition in aging and Alzheimer's disease. Ann. Neurol. 69 (2011), 181–192, 10.1002/ana.22248.
Wang, S.-S., Zhang, Z., Zhu, T.-B., Chu, S.-F., He, W.-B., Chen, N.-H., Myelin injury in the central nervous system and Alzheimer's disease. Brain Res. Bull. 140 (2018), 162–168, 10.1016/j.brainresbull.2018.05.003.
Weiskopf, N., Callaghan, M.F., Josephs, O., Lutti, A., Mohammadi, S., Estimating the apparent transverse relaxation time (R2*) from images with different contrasts (ESTATICS) reduces motion artifacts. Front. Neurosci., 8, 2014, 27, 10.3389/fnins.2014.00278.
Weiskopf, N., Suckling, J., Williams, G., Correia, M.M., Inkster, B., Tait, R., Ooi, C., Bullmore, E.T., Lutti, A., Quantitative multi-parameter mapping of R1, PD*, MT, and R2* at 3T: a multi-center validation. Front. Neurosci., 7, 2013, 95, 10.3389/fnins.2013.00095.
Wirth, M., Bejanin, A., La Joie, R., Arenaza-Urquijo, E.M., Gonneaud, J., Landeau, B., Perrotin, A., Mézenge, F., de La Sayette, V., Desgranges, B., Chételat, G., Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer's disease. Neurobiol. Aging 63 (2018), 140–151, 10.1016/j.neurobiolaging.2017.10.023.
Yin, X., Qian, W., Qiu, Y., Zhao, C., Zhou, Z., Bao, J., The role of amyloid-beta and tau in the early pathogenesis of Alzheimer's disease. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 27 (2021), e933084-1–e933084-7, 10.12659/MSM.933084.
Zecca, L., Youdim, M.B.H., Riederer, P., Connor, J.R., Crichton, R.R., Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5 (2004), 863–873, 10.1038/nrn1537.
Zeineh, M.M., Chen, Y., Kitzler, H.H., Hammond, R., Vogel, H., Rutt, B.K., Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer's disease. Neurobiol. Aging 36 (2015), 2483–2500, 10.1016/j.neurobiolaging.2015.05.022.